Title:
BIOMARKER FOR DIAGNOSING ALZHEIMER'S DISEASE AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/140653
Kind Code:
A1
Abstract:
The present invention relates to a composition and kit for diagnosis of Alzheimer's disease by using a novel miRNA biomarker to diagnose Alzheimer's disease and a method for providing information for diagnosis of Alzheimer disease, using same. In the present invention, a novel biomarker capable of predicting Alzheimer's disease is proposed to provide a composition and kit for diagnosis of Alzheimer's disease, whereby patients with Alzheimer's disease can be diagnosed promptly and accurately, and a suitable therapy can be provided for patients with Alzheimer's disease.
Inventors:
SHIN YONG BEOM (KR)
KIM YOUNG JUN (KR)
KIM SANG YUN (KR)
PARK YOUNG HO (KR)
CHO HYUN MIN (KR)
CHUNG DA JUNG (KR)
BAE PAN KEE (KR)
KIM YOUNG JUN (KR)
KIM SANG YUN (KR)
PARK YOUNG HO (KR)
CHO HYUN MIN (KR)
CHUNG DA JUNG (KR)
BAE PAN KEE (KR)
Application Number:
PCT/KR2023/000955
Publication Date:
July 27, 2023
Filing Date:
January 19, 2023
Export Citation:
Assignee:
BIONANO HEALTH GUARD RES CENTER (KR)
SEOUL NAT UNIV HOSPITAL (KR)
SEOUL NAT UNIV HOSPITAL (KR)
International Classes:
C12Q1/6883
Domestic Patent References:
| WO2013055865A1 | 2013-04-18 |
Foreign References:
| JP2021121187A | 2021-08-26 | |||
| JP2017184642A | 2017-10-12 |
Other References:
LI QINGQIN S., CAI DIANA: "Integrated miRNA-Seq and mRNA-Seq Study to Identify miRNAs Associated With Alzheimer’s Disease Using Post-mortem Brain Tissue Samples", FRONTIERS IN NEUROSCIENCE, vol. 15, XP093079207, DOI: 10.3389/fnins.2021.620899
DATABASE NUCLEOTIDE ANONYMOUS : "Homo sapiens LNC_000421 lncRNA, complete sequence", XP093079209, retrieved from NCBI
DATABASE NUCLEOTIDE ANONYMOUS : "Homo sapiens LNC_000421 lncRNA, complete sequence", XP093079209, retrieved from NCBI
Attorney, Agent or Firm:
PCR INTELLECTUAL PROPERTY LAW FIRM (KR)
Download PDF: